Skip to main content
Fig. 2 | Journal of Intensive Care

Fig. 2

From: Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study

Fig. 2

Mean blood pressure and heart rate over time. Blood pressure and heart rate were monitored during the administration of the study drug and measured at pre-dosing and at 5, 10, 15, 20, and 30 min, 1, 2, and every 2 h after the start of dosing. Vital signs were also measured before and after a change in infusion rate of study drug, rescue fentanyl administration, a change in sedative infusion rate and a termination of dosing of study drug, but these values are not included in the figure. DBP diastolic blood pressure, HR heart rate, SBP  systolic blood pressure

Back to article page

Journal of Intensive Care

ISSN: 2052-0492